ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
- Written by Newsfile
New York, New York--(Newsfile Corp. - August 6, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December 15, 2021 and June 28, 2023, both dates inclusive (the "Class Period"), of the important September 5, 2023 lead plaintiff deadline.
SO WHAT: If...